BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 25728464)

  • 1. Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
    Carolina Rojas O; León-Cachón RB; Pérez-Maya AA; Aguirre-Garza M; Moreno-Treviño MG; González GM
    Mycoses; 2015 May; 58(5):267-72. PubMed ID: 25728464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
    de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
    Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
    Yang YP; Li W; Huang WM; Zhou Y; Fan YM
    Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.
    Coelho RA; Brito-Santos F; Figueiredo-Carvalho MHG; Silva JVDS; Gutierrez-Galhardo MC; do Valle ACF; Zancopé-Oliveira RM; Trilles L; Meyer W; Freitas DFS; Almeida-Paes R
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006675. PubMed ID: 30048450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular identification of chromoblastomycosis clinical isolates in Guangdong.
    Fransisca C; He Y; Chen Z; Liu H; Xi L
    Med Mycol; 2017 Nov; 55(8):851-858. PubMed ID: 28053146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromoblastomycosis due to Fonsecaea pedrosoi and F. monophora in Cuba.
    Badali H; Fernández-González M; Mousavi B; Illnait-Zaragozi MT; González-Rodríguez JC; de Hoog GS; Meis JF
    Mycopathologia; 2013 Jun; 175(5-6):439-44. PubMed ID: 23471535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.
    Andrade TS; Castro LG; Nunes RS; Gimenes VM; Cury AE
    Mycoses; 2004 Jun; 47(5-6):216-21. PubMed ID: 15189187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular phylogenetics of Fonsecaea strains isolated from chromoblastomycosis patients in South Korea.
    Lim SW; Suh MK; Kang GS; Ha GY; Kim H; Choi JS; Kim YS
    Mycoses; 2011 Sep; 54(5):e415-20. PubMed ID: 21910758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China.
    Yu J; Li R; Zhang M; Liu L; Wan Z
    Med Mycol; 2008 Nov; 46(7):745-7. PubMed ID: 18608889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
    Romero-Navarrete M; Ruíz LF; Castillo A; Arenas R; Vega-Memije ME; Xicohtencatl-Cortes J; Espinoza-Rivera M; Hernández-Castro R
    J Mycol Med; 2018 Dec; 28(4):663-665. PubMed ID: 30126716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
    Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
    Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diversity of Cladophialophora carrionii in patients with chromoblastomycosis in Venezuela.
    González GM; Rojas OC; Bocanegra-García V; González JG; Garza-González E
    Med Mycol; 2013 Feb; 51(2):170-7. PubMed ID: 22734968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
    Najafzadeh MJ; Badali H; Illnait-Zaragozi MT; De Hoog GS; Meis JF
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1636-8. PubMed ID: 20086140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromoblastomycosis caused by Fonsecaea monophora in Mexico.
    Campos-Macias P; Arenas R; Aquino CJ; Romero-Navarrete M; Martínez-Hernández F; Martínez-Chavarría LC; Xicohtencatl-Cortes J; Hernández-Castro R
    J Mycol Med; 2021 Jun; 31(2):101114. PubMed ID: 33684836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy.
    Criado PR; Careta MF; Valente NY; Martins JE; Rivitti EA; Spina R; Belda W
    J Dermatolog Treat; 2011 Jun; 22(3):167-74. PubMed ID: 20666671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fonsecaea nubica sp. nov, a new agent of human chromoblastomycosis revealed using molecular data.
    Najafzadeh MJ; Sun J; Vicente V; Xi L; van den Ende AH; de Hoog GS
    Med Mycol; 2010 Sep; 48(6):800-6. PubMed ID: 20302550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis.
    Daboit TC; Magagnin CM; Heidrich D; Castrillón MR; Mendes SD; Vettorato G; Valente P; Scroferneker ML
    Mycopathologia; 2013 Aug; 176(1-2):139-44. PubMed ID: 23645135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China.
    Xi L; Sun J; Lu C; Liu H; Xie Z; Fukushima K; Takizawa K; Najafzadeh MJ; De Hoog GS
    Med Mycol; 2009 Feb; 47(1):27-33. PubMed ID: 18951291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil.
    Guevara A; Nery AF; de Souza Carvalho Melhem M; Bonfietti L; Rodrigues AM; Hagen F; de Carvalho JA; de Camargo ZP; de Souza Lima BJF; Vicente VA; Hahn RC
    Mycoses; 2022 Dec; 65(12):1146-1158. PubMed ID: 35869803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
    Calvo E; Pastor FJ; Mayayo E; Hernández P; Guarro J
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3709-13. PubMed ID: 21576429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.